DEFA14A: Acurx Pharmaceuticals Sets Date for 2024 Annual Meeting, Outlines Voting Proposals

Acurx Pharmaceuticals announces its 2024 Annual Meeting of Stockholders to be held virtually on June 17, 2024, with proposals including the election of directors and ratification of independent auditors.

Summary

• Acurx Pharmaceuticals will hold its Annual Meeting of Stockholders virtually on June 17, 2024.
• Stockholders are invited to vote on key proposals, including the election of three directors: Robert J. DeLuccia, James Donohue, and Joseph C. Scodari.
• Another proposal involves ratifying the appointment of CohnReznick LLP as the company's independent registered public accountants for the fiscal year ending December 31, 2024.
• The proxy materials, including the Notice and Proxy Statement and Form 10-K, are available online.
• Stockholders can request a free paper or email copy of these materials before June 3, 2024.
• Voting can be done online at www.ProxyVote.com or virtually during the meeting.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment as it reflects routine corporate governance activities.

Positives

• The virtual format of the annual meeting allows for broader participation from stockholders.
• Stockholders have multiple options for accessing proxy materials and casting their votes, including online and by requesting physical copies.

Future Outlook

The document outlines the standard procedures for an annual meeting, focusing on governance and compliance matters.

Industry Context

This announcement is typical for publicly traded companies, ensuring shareholders are informed and can participate in key decisions regarding the company's governance.

Stakeholder Impact

• Shareholders can exercise their voting rights on key company decisions.
• The outcome of the votes will influence the composition of the board of directors and the selection of the company's independent auditor.

Next Steps

• Stockholders to review proxy materials and vote on the proposals.
• Acurx Pharmaceuticals to conduct the Annual Meeting on June 17, 2024.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, CohnReznick, Voting, Acurx Pharmaceuticals